“…However, EGFR expression rates are lower in laryngeal tumors versus squamous cell carcinoma of the oral cavity or oropharynx (2). Several autocrine ligands, including TGFα and amphiregulin, activate the EGFR receptor, forming a dimer, which causes ATP-dependent autophosphorylation of the intracellular tyrosine residues (23). Upon phosphorylation, EGFR can trigger several downstream pathways, including PI3-K/Akt, sending anti-apoptotic signals, and MAPK/ERK, regulating cell proliferation, tumor induced neovascularization, invasion and metastasis (2).…”